Caren Deardorf

Insider Reports History

Entity
Individual
Location
C/O Magenta Therapeutics, Inc., 100 Technology Square, Cambridge, MA
Signature
Marc Wilson, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Caren Deardorf:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Crinetics Pharmaceuticals, Inc. Director Common Stock 9.4K $446K $47.49 Jun 7, 2024 Direct
Magenta Therapeutics, Inc. Chief Commercial Officer Common Stock 19.8K $237K $12.00 Nov 30, 2022 Direct
Magenta Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 75K Aug 1, 2022 Direct
Crinetics Pharmaceuticals, Inc. Director Stock Option (right to buy) 12.5K Jun 7, 2024 Direct

Insider Reports Filed by Caren Deardorf

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRNX Crinetics Pharmaceuticals, Inc. Jun 7, 2024 2 $0 4 Jun 11, 2024 Director
CRNX Crinetics Pharmaceuticals, Inc. Jun 16, 2023 2 $0 4 Jun 21, 2023 Director
DNTH Magenta Therapeutics, Inc. Nov 30, 2022 1 $2.82K 4 Dec 2, 2022 Chief Commercial Officer
DNTH Magenta Therapeutics, Inc. Aug 1, 2022 1 $0 4 Aug 1, 2022 Chief Commercial Officer
CRNX Crinetics Pharmaceuticals, Inc. Jun 17, 2022 1 $0 4 Jun 21, 2022 Director
DNTH Magenta Therapeutics, Inc. May 31, 2022 1 $2.97K 4 Jun 6, 2022 Chief Commercial Officer
DNTH Magenta Therapeutics, Inc. May 17, 2022 1 $0 4 May 19, 2022 Chief Commercial Officer
CRNX Crinetics Pharmaceuticals, Inc. Mar 11, 2022 1 $0 4/A Apr 4, 2022 Director
CRNX Crinetics Pharmaceuticals, Inc. Mar 11, 2022 0 $0 3 Mar 14, 2022 Director
DNTH Magenta Therapeutics, Inc. Feb 15, 2022 1 $0 4 Feb 17, 2022 Chief Commercial Officer
DNTH Magenta Therapeutics, Inc. Sep 16, 2021 1 -$42K 4 Sep 20, 2021 Chief Commercial Officer
DNTH Magenta Therapeutics, Inc. Sep 14, 2021 1 $0 4 Sep 16, 2021 Chief Commercial Officer
DNTH Magenta Therapeutics, Inc. Jul 6, 2021 1 $0 4 Jul 8, 2021 Chief Commercial Officer
DNTH Magenta Therapeutics, Inc. Jul 6, 2021 0 $0 3 Jul 8, 2021 Chief Commercial Officer